Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

321 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Paromomycin.
Davidson RN, den Boer M, Ritmeijer K. Davidson RN, et al. Among authors: den boer m. Trans R Soc Trop Med Hyg. 2009 Jul;103(7):653-60. doi: 10.1016/j.trstmh.2008.09.008. Epub 2008 Oct 23. Trans R Soc Trop Med Hyg. 2009. PMID: 18947845 Review.
Treatment options for visceral leishmaniasis.
den Boer M, Davidson RN. den Boer M, et al. Expert Rev Anti Infect Ther. 2006 Apr;4(2):187-97. doi: 10.1586/14787210.4.2.187. Expert Rev Anti Infect Ther. 2006. PMID: 16597201 Review.
Liposomal amphotericin B for the treatment of visceral leishmaniasis.
Bern C, Adler-Moore J, Berenguer J, Boelaert M, den Boer M, Davidson RN, Figueras C, Gradoni L, Kafetzis DA, Ritmeijer K, Rosenthal E, Royce C, Russo R, Sundar S, Alvar J. Bern C, et al. Among authors: den boer m. Clin Infect Dis. 2006 Oct 1;43(7):917-24. doi: 10.1086/507530. Epub 2006 Aug 28. Clin Infect Dis. 2006. PMID: 16941377
Developments in the treatment of visceral leishmaniasis.
den Boer ML, Alvar J, Davidson RN, Ritmeijer K, Balasegaram M. den Boer ML, et al. Expert Opin Emerg Drugs. 2009 Sep;14(3):395-410. doi: 10.1517/14728210903153862. Expert Opin Emerg Drugs. 2009. PMID: 19708817 Free article. Review.
Hypokalaemia-induced rhabdomyolysis after treatment of post-Kala-azar dermal Leishmaniasis (PKDL) with high-dose AmBisome in Bangladesh-a case report.
Marking U, den Boer M, Das AK, Ahmed EM, Rollason V, Ahmed BN, Davidson RN, Ritmeijer K. Marking U, et al. Among authors: den boer m. PLoS Negl Trop Dis. 2014 Jun 12;8(6):e2864. doi: 10.1371/journal.pntd.0002864. eCollection 2014 Jun. PLoS Negl Trop Dis. 2014. PMID: 24922279 Free PMC article. No abstract available.
"Kala-Azar is a Dishonest Disease": Community Perspectives on Access Barriers to Visceral Leishmaniasis (Kala-Azar) Diagnosis and Care in Southern Gadarif, Sudan.
Sunyoto T, Adam GK, Atia AM, Hamid Y, Babiker RA, Abdelrahman N, Vander Kelen C, Ritmeijer K, Alcoba G, den Boer M, Picado A, Boelaert M. Sunyoto T, et al. Among authors: den boer m. Am J Trop Med Hyg. 2018 Apr;98(4):1091-1101. doi: 10.4269/ajtmh.17-0872. Epub 2018 Feb 22. Am J Trop Med Hyg. 2018. PMID: 29488462 Free PMC article.
Barriers to access to visceral leishmaniasis diagnosis and care among seasonal mobile workers in Western Tigray, Northern Ethiopia: A qualitative study.
Coulborn RM, Gebrehiwot TG, Schneider M, Gerstl S, Adera C, Herrero M, Porten K, den Boer M, Ritmeijer K, Alvar J, Hassen A, Mulugeta A. Coulborn RM, et al. Among authors: den boer m. PLoS Negl Trop Dis. 2018 Nov 8;12(11):e0006778. doi: 10.1371/journal.pntd.0006778. eCollection 2018 Nov. PLoS Negl Trop Dis. 2018. PMID: 30408042 Free PMC article.
321 results